Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

The intrinsic role of endogenous IL-17A in spontaneous intestinal tumorigenesis has not been addressed previously to our knowledge. Ablation of IL-17A significantly reduced tumor development in mice bearing a heterozygote mutation in the adenomatous polyposis coli (APC) gene (ApcMin/⁺ mice). There w...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 107; no. 12; pp. 5540 - 5544
Main Authors Chae, Wook-Jin, Gibson, Thomas F, Zelterman, Daniel, Hao, Liming, Henegariu, Octavian, Bothwell, Alfred L.M
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 23.03.2010
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The intrinsic role of endogenous IL-17A in spontaneous intestinal tumorigenesis has not been addressed previously to our knowledge. Ablation of IL-17A significantly reduced tumor development in mice bearing a heterozygote mutation in the adenomatous polyposis coli (APC) gene (ApcMin/⁺ mice). There was also a decrease in inflammatory cytokines and proinflammatory mediators, reduced infiltration of lymphocytes including T cells, and preservation of intestinal architecture and the presence of APC protein in intestinal epithelial cells. Interestingly, IL-17A ablation also corrected immunological abnormalities such as splenomegaly and thymic atrophy in ApcMin/⁺ mice. CD4 T cells from ApcMin/⁺ mice showed hyperproliferative potential in vitro and in vivo and increased levels of IL-17A and IL-10. The effector CD4 T cells from ApcMin/⁺ mice were more resistant to regulatory T cell-mediated suppression. Finally, these CD4 T cells induced colitis in immunodeficient mice upon adoptive transfer, whereas the ablation of IL-17A in CD4 T cells in ApcMin/⁺ mice completely abolished this pathogenic potential in vivo. Taken together, our results show that CD4 T cell-derived IL-17A promotes spontaneous intestinal tumorigenesis with altered functions of CD4 T cells in ApcMin/⁺ mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: W.J.C. and A.L.M.B. designed research; W.J.C., T.G., and O.H. performed research; W.J.C., D.Z., L.M.H., and A.L.M.B. analyzed data; and W.J.C. and A.L.M.B. wrote the paper.
Edited* by Richard A, Flavell, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, CT, and approved February 9, 2010 (received for review November 3, 2009)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0912675107